Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

BioNexus Gene Lab (BGLC) Interest Coverage Ratio (2021 - 2025)

BioNexus Gene Lab's Interest Coverage Ratio history spans 5 years, with the latest figure at 315.66 for Q4 2025.

  • Quarterly results put Interest Coverage Ratio at 315.66 for Q4 2025, down 340.78% from a year ago — trailing twelve months through Dec 2025 was 151.73 (down 103.88% YoY), and the annual figure for FY2025 was 151.73, down 103.88%.
  • Interest Coverage Ratio for Q4 2025 was 315.66 at BioNexus Gene Lab, down from 108.38 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 89.48 in Q2 2023 to a low of 593.69 in Q3 2023.
  • The 5-year median for Interest Coverage Ratio is 50.44 (2021), against an average of 79.94.
  • Peak annual rise in Interest Coverage Ratio hit 250.41% in 2023, while the deepest fall reached 1986.25% in 2023.
  • Year by year, Interest Coverage Ratio stood at 50.44 in 2021, then surged by 151.08% to 25.76 in 2022, then skyrocketed by 139.17% to 61.62 in 2023, then crashed by 216.22% to 71.61 in 2024, then tumbled by 340.78% to 315.66 in 2025.
  • According to Business Quant data, Interest Coverage Ratio over the past three periods came in at 315.66, 108.38, and 125.29 for Q4 2025, Q3 2025, and Q2 2025 respectively.